Taylor & Francis Group
Browse
DOCUMENT
SupFig1.pdf (438.57 kB)
DOCUMENT
Revised_Supplemental_Tables_SLR_mUC_under_treatment_MS_FutOncol_22JUNE2023.docx (498.13 kB)
1/0
2 files

Undertreatment in Patients with Advanced Urothelial Cancer: Systematic Literature Review and Meta-Analysis - supplementary material

dataset
posted on 2023-08-01, 11:01 authored by Mairead Kearney, Liu Zhang, Elizabeth Hubscher, Mihaela Musat, Sharada Harricharan, Thomas Wilke

Supplementary figure and tables

Supplementary Table 1. PICOS criteria

Supplementary Table 2. SLR search strategy

Supplementary Table 3. NST study summary by category

Supplementary Table 4. Risk of bias via modified Newcastle-Ottawa Scale

Supplementary Table 5. List of included studies and reported NST or attrition rates

Supplementary Table 6. Records selected at full-text stage but not extracted due to 1) not specifying period when data was acquired, or 2) not reporting NST or attrition rates


Funding

Merck (CrossRef Funder ID: 10.13039/100009945), (Grant / Award Number: ) Pfizer, (Grant / Award Number: )

History